Your search for multiple sclerosis returned 167 results

Your search for multiple sclerosis returned 167 results

Sort Results:

Relevant Recent
Neurology Information Center

Multiple Sclerosis Update From ACTRIMS Forum 2023

Research findings from Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2023 provide updates on MS diagnosis and treatment.

Health Awareness Months 2023

Health awareness campaigns occur all throughout the year in a wide variety of medical fields. These are when health awareness days, weeks, and months are happening this year.
News, Stat Consult

Stat Consult: Multiple Sclerosis

This review provides a concise overview of the types, pathogenesis, diagnostic criteria, differential diagnosis, and treatment of multiple sclerosis.
Web Exclusives

FDA approves Tecfidera for MS

Dimethyl fumarate is the third oral medication available to treat multiple sclerosis.
Evidence-Based Medicine

Dalfampridine approved for multiple sclerosis

Level 3: Lacking direct evidence Dalfampridine (Ampyra) extended release tablets, previously called Fampridine-SR, have been approved by the FDA to improve walking in patients with multiple sclerosis. In two clinical trials with 507 patients, the drug was associated with consistent improvement in walking speed on a 25-foot walk when compared with placebo (NNT 4). However,…
Next post in Neurology Information Center